(Date:5/21/2013)... 2013 Savoury Systems International (SSI), a ... Braddy to Southeastern USA Sales Broker. Braddy’s new role ... in the Southeast. , In 2004 Braddy ... supplier to food processors and industrial manufacturers. Braddy ... food industry and has over 25 years of sales ...
(Date:5/21/2013)... 21, 2013 According to a ... http://www.transparencymarketresearch.com ) "Biochip Products and Services Market (Microarrays, Reagents, ... Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," the market ... is expected to grow at a CAGR of 10.1% ... of USD 4.7 billion in 2018. Browse ...
(Date:5/21/2013)... PA (PRWEB) May 21, 2013 ... today announced that Dr. Charles Signorino, the Company’s Chief ... April 1, 2013 after 32 years of service. As ... Gomez, Emerson’s current President, has been named as Dr. ... luminary in the pharmaceutical industry, having made a significant ...
(Date:5/21/2013)... May 21, 2013 Personal Genome Diagnostics Inc. ... proprietary methodologies and expertise in genomic analysis of ... in collaboration with Blueprint Medicines. PGDx is an ... genomic alterations in tumors, and Blueprint Medicines is ... for a genetically defined patient population. ...
Breaking Biology Technology:The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 2The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 4The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 5Emerson Resources Announces CEO Retirement and Appointment of Successor 2Emerson Resources Announces CEO Retirement and Appointment of Successor 3Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 2Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 3... PITTSBURGH, March 30 Mylan Inc. (Nasdaq: ... India-based subsidiary in which it holds a 71.2% controlling ... U.S. Food and Drug Administration (FDA) under the President,s ... New Drug Application (ANDA) for Emtricitabine and Tenofovir Disoproxil ...
... Inverness Medical Innovations, Inc. (NYSE: IMA ), a ... health at home through the merger of rapid diagnostics and ... on its Series B Convertible Perpetual Preferred Stock (NYSE: IMA-PB). ... stock in an amount per share equal to the quotient ...
... Inc. (Nasdaq: GSIG ), a supplier of precision ... errors related to timing of the recognition of revenue from ... fiscal year 2006. The Audit Committee of the Board of ... potential adjustments resulting from the identified errors is material to ...
Cached Biology Technology:Mylan's Matrix Receives First Tentative FDA Approval Under PEPFAR for Generic Truvada(R) 2GSI Group Inc. to Restate Financial Results for 2006 2Control primers and template for 5kb and 15 kb products....
Carrier Serum...
The Lambda Control Kit contains lambda DNA and two 25mer primers, which can be used to amplify a 500bp fragment. The lambda DNA is purified by CsCl gradient centrifugation and organic extraction foll...
A robust formulation of Taq Polymerase supplied with a 10X colored reaction buffer which allows Direct Gel-Loading...
Biology Products:Biology NavigationMedical Navigation